A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

GlaxoSmithKline: Attention Is Now Shifting To Vaccine Manufacturing Aug. 21, 2020 9:39 AM ET GSK plc (GSK) Stock AZN , DVAX , IBIO , MRNA , PFE , SNY , VIR , GSK 27 Comments 19 Likes Chetan Woodun ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant.

Earlier this year, GSK said it would invest £200 million (around $260 million) in upgrades to its manufacturing network in the UK, including a revamp of a plant in Melrose, Scotland, used to make ...

GlaxoSmithKline, an early adopter of continuous processing as a way to cut drug manufacturing costs and manufacturing waste, and thus its impact on the environment, is committing $25 million to ...

GSK says EU pharma legislation overhaul could trigger investment shift ... goal of improving access to medicines for all Europeans and that the region was critical to GSK's R&D and manufacturing.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...

GSK’s U.K. manufacturing staffers are no longer merely threatening to strike. ... In its “final offer,” GSK agreed to a 6% increase in base pay, shift pay and allowances, ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant.